Home | Radiation Oncology | Treatment Therapies | Research & Clinical Trials | RTOG
RTOG
All of three of our centers are RTOG Member Institutions. This membership provides us the ability to offer NCI Cooperative Group Clinical Trials to our patients.
RTOG (Radiation Therapy Oncology Group) is part of the Clinical Trials Cooperative Group Program. The Clinical Trials Cooperative Group Program, which is sponsored by the National Cancer Institute (NCI), is designed to promote and support clinical trials (research studies) of new cancer treatments, explore methods of cancer prevention and early detection, and study quality-of-life issues and rehabilitation during and after cancer treatment. Cooperative groups include researchers, cancer centers, and community physicians throughout the United States, Canada, and Europe. They work with the NCI to identify important questions in cancer research and to design clinical trials to answer these questions.
There are approximately 40 active RTOG clinical trials at this time from which our physicians can choose to open at our centers. RTOG membership also permits access to the Clinical Trials Support Unit (CTSU) which presently offers over 60 active clinical trials from multiple Cooperative Groups. The CTSU is another NCI sponsored program developed to help increase physician and patient access to NCI-sponsored clinical trials.
The physicians at our centers collaborate with the Medical Oncologists, Urologists, Surgeons, and various other specialists at our affiliate and referring hospitals to determine which clinical trials they would like to see open and available to their patients. These trials are then presented to an Institutional Review Board (IRB) for approval. Dr. Bruce Bornstein is our center’s Principal Investigator and is available to discuss all inquiries related to our clinical trials program.
